Lung Cancer Drug Tabrecta Approved By The FDA — New Hope For People With a Specific Biomarker

Published May 7, 2020

Lung Cancer Drug Tabrecta Approved By The FDA — New Hope For People With a Specific Biomarker

The FDA's approval of Tabrecta marks a historic step in treatment for patients battling aggressive lung cancer. Researchers say this is just the beginning.

NOW
PLAYING
New Hope For Stomach Cancer: Immunotherapy Drug Opdivo Now Approved As a First Treatment
NOW
PLAYING
A New Option for Some People With Lung Cancer: How This Immunotherapy/Chemotherapy Combo Can Increase Treatment Success
NOW
PLAYING
'Raindrops Keep Fallin' on My Head' Singer B.J. Thomas, 78, Diagnosed with Stage 4 Lung Cancer; 'I Ask All of You for Your Prayers'
NOW
PLAYING
Can Metastatic Bladder Cancer Be Treated With Immunotherapy?
NOW
PLAYING
Exploring the Treatment Options for Metastatic Bladder Cancer
NOW
PLAYING
FDA Approves Lorlatinib to Treat Some Cases of Lung Cancer

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.